MedPath

Feasibility and Acceptability of Stress Induction, Physiological Data Collection, and Mindfulness-Based Stress Reduction Among Combat Veterans With PTSD

Not Applicable
Terminated
Conditions
Ptsd
Interventions
Behavioral: Mindfulness-Based Stress Reduction (MBSR)
Behavioral: Health and Wellness Education (HWE)
Registration Number
NCT05938816
Lead Sponsor
Oregon Health and Science University
Brief Summary

Investigators will recruit up to 20 veterans with PTSD. Participants will be randomized into two conditions: MBSR and Health and Wellness Education (HWE; control group). Participants will be randomized at a 1:1 ratio. Purpose of the study is to learn how mindfulness meditation may be helpful in treating PTSD. Participants will undergo 2 screening sessions, 8 weekly sessions of intervention (MBSR or HWE), 3 laboratory visits that will include completing survey questionnaires, stress test and recording of heart rate, blood pressure and breathing rate.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Adult (18-85yo)
  • Military veteran
  • Experiencing PTSD symptoms
  • Reading and speaking in English
  • Be able to travel to OHSU for three two-hour lab visits, 8 weekly intervention sessions and one long extended session, and a two- hour focus group
Exclusion Criteria
  • Pregnancy
  • Severe untreated depression, cognitive impairment, or active suicidality*
  • Life-threatening or severely disabling medical conditions
  • Excessive use of alcohol, nicotine, or cannabis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mindfulness-Based Stress ReductionMindfulness-Based Stress Reduction (MBSR)-
Health and Wellness EducationHealth and Wellness Education (HWE)-
Primary Outcome Measures
NameTimeMethod
Qualitative Interview Targeting Feasibility of MBSR2 weeks post conclusion of intervention

Qualitative data generated via focus group interviews. Questions will include common barriers to completing the intervention and strategies utilized by participants to maximize adherence.

Qualitative Interview Targeting Acceptability of MBSR2 weeks post conclusion of intervention. Data were not collected due to prematurely study closure due to PI change of career.

Qualitative data generated via focus group interviews. Questions will include ratings of the relevance of the content presented to participants' lives, as well as assessment of the method of presentation.

Secondary Outcome Measures
NameTimeMethod
Psychological Resilience 1Pre (week 0), mid (week 4), and post intervention (week 10). Data were not collected due to prematurely study closure due to PI change of career.

Measured by self-report measure: Brief Resilience Scale (BRS). Scale ranges from 1-5 and higher scores indicate higher psychological resilience.

Blood Pressure ReactivityPre (week 0), mid (week 4), and post intervention (week 10).

Reactivity of physiological parameters (e.g., systolic and diastolic blood pressure) to a cognitive stress task.

PTSD Symptoms 1Pre (week 0), mid (week 4), and post intervention (week 10).

Measured by a self-report questionnaire: the PTSD Symptom Checklist (PCL). Scores range from 0-4 and higher scores indicate more severe PTSD symptoms.

Psychological Resilience 2Pre (week 0), mid (week 4), and post intervention (week 10).

Measured by self-report measure: Connor-Davidson Resilience Scale (CD-RISC). Scores range from 0-4 and higher scores indicate higher psychological resilience.

PTSD SymptomsPre (week 0), mid (week 4), and post intervention (week 10).

Measured a clinician-administered semi-structured interview: the Clinician-Administered PTSD Scale (CAPS-5). Symptoms are rated for severity (0-absent; 1-mild/subthreshold; 2-moderate/threshold; 3-severe/markedly elevated; 4-extreme/incapacitating) and the presence of distress (minimal; clearly present; pronounced; extreme). Symptom clusters are also rated for the likelihood that they are related to the index trauma (definite; probable; unlikely).

Trial Locations

Locations (1)

OHSU

🇺🇸

Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath